Reduced Immunogenicity and Enhanced Transduction in Engineered AAV2 Vectors
Despite the proven safety and efficacy of adeno-associated virus serotype 2 (AAV2) vectors in gene therapy, their clinical application is often limited by dose-dependent immune responses, particularly CD8+ T cell…